Statute Details
- Title: Medicines (Veterinary Medicinal Products) (Exemption) Order
- Act Code: MA1975-OR1
- Legislative Type: Subsidiary legislation (SL)
- Authorising Act: Medicines Act (Chapter 176), Section 9
- Key Provisions (as extracted): Section 1 (Citation); Section 2 (Exemption)
- Current Version Status: Current version as at 27 Mar 2026
- Original Citation / Gazette Reference: G.N. No. S 143/77 (as indicated in the extract)
- Revised Editions Noted in Legislative History: 25 Mar 1992 (1990 RevEd); 31 Jan 2000 (2000 RevEd)
What Is This Legislation About?
The Medicines (Veterinary Medicinal Products) (Exemption) Order is a short but legally significant instrument within Singapore’s medicines regulatory framework. In plain terms, it creates a targeted exemption for veterinary medicinal products from a specific prohibition in the Medicines Act—namely, the prohibition against manufacture and wholesale dealing of medicinal products.
Singapore’s Medicines Act generally regulates medicinal products to protect public health and ensure that medicinal products are manufactured, handled, and distributed under appropriate controls. However, the regulatory approach recognises that veterinary medicinal products may be subject to different practical realities and regulatory pathways. This Order therefore carves out an exemption, so that the general prohibition in the Act does not automatically apply to veterinary medicinal products.
Although the Order is brief, it matters for compliance planning. For practitioners advising manufacturers, wholesalers, importers, or distributors in the veterinary sector, the exemption can affect whether certain activities are prohibited outright under the Medicines Act or whether they are instead governed by other requirements (for example, licensing, registration, or other regulatory controls that may apply to veterinary medicinal products).
What Are the Key Provisions?
Section 1 (Citation) provides the formal name of the instrument: the Medicines (Veterinary Medicinal Products) (Exemption) Order. While this is standard legislative drafting, it is important for legal referencing in submissions, compliance documentation, and regulatory correspondence.
Section 2 (Exemption) is the operative provision. It states that Section 6 of the Medicines Act—which contains the prohibition against manufacture and wholesale dealing of medicinal product—shall not apply to veterinary medicinal products.
In practical terms, Section 2 means that the specific “prohibition” mechanism in Section 6 is lifted for veterinary medicinal products. A lawyer advising a business in this space should therefore treat the exemption as removing the automatic statutory bar that would otherwise apply to manufacturing and wholesale dealing of medicinal products.
However, the exemption is not necessarily a blanket permission to do anything with veterinary medicinal products. The Order only addresses the applicability of Section 6 of the Act. Other provisions of the Medicines Act (and any subsidiary legislation, licensing conditions, or regulatory requirements) may still apply. For example, there may be separate requirements relating to registration/authorisation, quality control, labelling, storage, distribution controls, or licensing regimes. The exemption should be read as a narrow legal adjustment to the scope of the Section 6 prohibition, not as a general deregulation of veterinary medicinal products.
It is also important to note the drafting technique: the Order does not define “veterinary medicinal products” in the extract provided. In practice, practitioners should consult the Medicines Act and any relevant definitions in the parent Act or other subsidiary instruments to confirm the scope of the term. The exemption’s usefulness depends on whether the product in question falls within the statutory definition of a “veterinary medicinal product.”
How Is This Legislation Structured?
The Order is structured in a simple two-section format:
- Section 1: Citation (how the Order is referred to).
- Section 2: Exemption (the substantive legal effect).
There are no additional parts or detailed schedules in the extract. This structure indicates that the legislative intent is to provide a focused exemption rather than a comprehensive regulatory scheme. The Order functions as a “switch” that changes the applicability of a particular prohibition in the Medicines Act.
Who Does This Legislation Apply To?
The exemption applies to persons and entities whose activities fall within the scope of manufacture and wholesale dealing of veterinary medicinal products. In other words, the exemption is relevant to businesses engaged in the veterinary medicines supply chain—such as manufacturers, wholesalers, and other market participants whose activities could otherwise be caught by the Medicines Act’s prohibition.
Because the Order is framed as an exemption from a provision of the Medicines Act, it applies regardless of the identity of the regulated party, provided the activity is within the relevant conduct category (manufacture/wholesale dealing) and the product is within the relevant product category (veterinary medicinal products). Practitioners should therefore assess both elements: (1) the nature of the product and (2) the nature of the regulated activity.
Why Is This Legislation Important?
Even though the Order is short, it can have significant compliance consequences. If Section 6 of the Medicines Act would otherwise prohibit manufacture and wholesale dealing of medicinal products, then without an exemption, businesses could face legal risk for engaging in those activities. By exempting veterinary medicinal products from Section 6, the Order reduces the risk that routine veterinary medicines manufacturing or wholesale distribution is automatically unlawful under that specific prohibition.
For practitioners, the key value of this Order is in risk assessment and regulatory strategy. When advising a client, counsel should not only identify that an exemption exists, but also determine what regulatory framework governs the exempted activities. The exemption may mean that the client’s operations are permissible subject to other controls, such as licensing, product authorisation, or quality and distribution requirements. In practice, the exemption can affect how counsel structures advice on approvals, compliance steps, and enforcement exposure.
From an enforcement perspective, the Order clarifies the boundary of the Medicines Act’s prohibition. Regulators and regulated parties can point to the exemption to determine whether enforcement should proceed under Section 6 for veterinary medicinal products. This can also influence how investigations are framed and what evidence is relevant (for example, whether the product qualifies as a veterinary medicinal product, and whether the conduct is properly characterised as manufacture or wholesale dealing).
Finally, the legislative history indicates that the Order has been carried through revised editions (including the 2000 Revised Edition). This continuity suggests that the exemption has remained a stable feature of Singapore’s regulatory approach for veterinary medicinal products. Practitioners should still verify the current version and any amendments, but the extract indicates that the exemption remains in force as at 27 Mar 2026.
Related Legislation
- Medicines Act (Chapter 176), including Section 6 (prohibition against manufacture and wholesale dealing of medicinal product) and Section 9 (authorising provision for subsidiary legislation)
Source Documents
This article provides an overview of the Medicines (Veterinary Medicinal Products) (Exemption) Order for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.